These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 38455766)
41. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer. Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338 [TBL] [Abstract][Full Text] [Related]
42. miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. Nikolova E; Laleva L; Milev M; Spiriev T; Stoyanov S; Ferdinandov D; Mitev V; Todorova A Noncoding RNA Res; 2024 Mar; 9(1):141-152. PubMed ID: 38035044 [TBL] [Abstract][Full Text] [Related]
43. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas. Paul Y; Mondal B; Patil V; Somasundaram K Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842 [TBL] [Abstract][Full Text] [Related]
44. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
45. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers. Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164 [TBL] [Abstract][Full Text] [Related]
46. A miRNA signature for defining aggressive phenotype and prognosis in gliomas. Barbano R; Palumbo O; Pasculli B; Galasso M; Volinia S; D'Angelo V; Icolaro N; Coco M; Dimitri L; Graziano P; Copetti M; Valori VM; Maiello E; Carella M; Fazio VM; Parrella P PLoS One; 2014; 9(10):e108950. PubMed ID: 25279461 [TBL] [Abstract][Full Text] [Related]
47. Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer. Kim DH; Park H; Choi YJ; Im K; Lee CW; Kim DS; Pack CG; Kim HY; Choi CM; Lee JC; Ji W; Rho JK Biomark Res; 2023 Sep; 11(1):80. PubMed ID: 37705067 [TBL] [Abstract][Full Text] [Related]
48. Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients. Géczi D; Nagy B; Szilágyi M; Penyige A; Klekner Á; Jenei A; Virga J; Birkó Z Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064637 [TBL] [Abstract][Full Text] [Related]
49. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture. Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261 [TBL] [Abstract][Full Text] [Related]
50. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma. Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539 [TBL] [Abstract][Full Text] [Related]
51. Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways. Reis PP; Drigo SA; Carvalho RF; Lopez Lapa RM; Felix TF; Patel D; Cheng D; Pintilie M; Liu G; Tsao MS Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726984 [TBL] [Abstract][Full Text] [Related]
52. Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer. Fu Z; Xu Y; Chen Y; Lv H; Chen G; Chen Y Biomed Res Int; 2021; 2021():9121478. PubMed ID: 34840985 [TBL] [Abstract][Full Text] [Related]
53. Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma. Ji B; Chen L; Cai Q; Guo Q; Chen Z; He D PeerJ; 2020; 8():e9943. PubMed ID: 33062427 [TBL] [Abstract][Full Text] [Related]
54. Circulating microRNAs are associated with early childhood obesity: results of the I.Family Study. Iacomino G; Russo P; Marena P; Lauria F; Venezia A; Ahrens W; De Henauw S; De Luca P; Foraita R; Günther K; Lissner L; Molnár D; Moreno LA; Tornaritis M; Veidebaum T; Siani A Genes Nutr; 2019; 14():2. PubMed ID: 30651891 [TBL] [Abstract][Full Text] [Related]
56. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis. Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H Front Immunol; 2018; 9():3099. PubMed ID: 30687316 [TBL] [Abstract][Full Text] [Related]
57. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles. Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334 [TBL] [Abstract][Full Text] [Related]
58. miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death. Yan F; Chen Y; Ye X; Zhang F; Wang S; Zhang L; Luo X Diagn Pathol; 2021 Jul; 16(1):67. PubMed ID: 34332589 [TBL] [Abstract][Full Text] [Related]
60. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy. Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X PeerJ; 2015; 3():e990. PubMed ID: 26056621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]